Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 200

1.

The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.

Eisemann N, Nolte S, Schnoor M, Katalinic A, Rohde V, Waldmann A.

BMC Urol. 2015 Apr 10;15(1):28. [Epub ahead of print]

PMID:
25885890
2.

[Erratum to: Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling].

Hübner J, Noftz MR, Schnoor M, Katalinic A.

Internist (Berl). 2015 Apr 9. [Epub ahead of print] German. No abstract available.

PMID:
25854122
3.

Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011.

Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Froehner M, Huber J.

Radiother Oncol. 2015 Mar 11. pii: S0167-8140(15)00118-8. doi: 10.1016/j.radonc.2015.02.024. [Epub ahead of print]

PMID:
25770874
4.

Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy.

Eisemann N, Schnoor M, Katalinic A.

Hematol Oncol. 2015 Mar 11. doi: 10.1002/hon.2198. [Epub ahead of print]

PMID:
25757806
5.

The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany.

Fick EM, Katalinic A, Waldmann A.

Cancer Res Treat. 2015 Jan 5. doi: 10.4143/crt.2014.099. [Epub ahead of print]

6.

[Timed up and go test for fingers in the form of the 20 cents test. Psychometric criteria of a simple performance test of fine motor skills].

Krupp S, Kasper J, Balck F, Schnoor M, Eisemann N, Lohse K, Brunk J, Katalinic A, Willkomm M.

Z Gerontol Geriatr. 2015 Feb;48(2):121-7. doi: 10.1007/s00391-014-0854-z. Epub 2015 Jan 14. German.

PMID:
25586324
7.

Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project.

Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Holländer NH.

Eur J Cancer. 2014 Dec 4. pii: S0959-8049(14)01113-7. doi: 10.1016/j.ejca.2014.11.006. [Epub ahead of print]

PMID:
25483784
8.

Recent cancer survival in Germany: An analysis of common and less common cancers.

Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H; GEKID Cancer Survival Working Group.

Int J Cancer. 2015 Jun 1;136(11):2649-58. doi: 10.1002/ijc.29316. Epub 2014 Nov 26.

PMID:
25380088
9.

[Are speed cameras able to reduce traffic noise disturbances? An intervention study in Luebeck].

Schnoor M, Waldmann A, Pritzkuleit R, Tchorz J, Gigla B, Katalinic A.

Gesundheitswesen. 2014 Dec;76(12):856-61. doi: 10.1055/s-0034-1390435. Epub 2014 Oct 28. German.

PMID:
25350390
10.

[The Health-Related Quality of Life as Measured with the SF-12v1 in Elderly People Living in Luebeck 2010/11 in Comparison with the German Norm Data in 1994.]

Peters E, Kasten M, Katalinic A, Waldmann A.

Gesundheitswesen. 2014 Oct 28. [Epub ahead of print] German.

PMID:
25350388
11.
12.

[Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling].

Hübner J, Noftz MR, Schnoor M, Katalinic A.

Internist (Berl). 2014 Oct;55(10):1171-81. doi: 10.1007/s00108-014-3601-z. German.

PMID:
25256406
13.

Benefits and risks of skin cancer screening.

Breitbart EW, Choudhury K, Anders MP, Volkmer B, Greinert R, Katalinic A, Tacke J, Keilholz U.

Oncol Res Treat. 2014;37 Suppl 3:38-47. doi: 10.1159/000364887. Epub 2014 Aug 29. No abstract available.

PMID:
25195831
14.

Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.

Eisemann N, Waldmann A, Garbe C, Katalinic A.

Med Decis Making. 2015 Feb;35(2):243-54. doi: 10.1177/0272989X14543106. Epub 2014 Aug 21.

PMID:
25145574
15.

Patients and Methods of the PATH Biobank - A Resource for Breast Cancer Research.

Waldmann A, Anzeneder T, Katalinic A.

Geburtshilfe Frauenheilkd. 2014 Apr;74(4):361-369.

16.

[Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges.]

Haug U, Rösch T, Hoffmeister M, Katalinic A, Brenner H, Becker N.

Gesundheitswesen. 2014 Jul 15. [Epub ahead of print] German.

PMID:
25025294
17.

Economic evaluation of cancer registration in Europe.

Zanetti R, Sacchetto L, Calvia M, Bordoni A, Hakulinen T, Znaor A, Møller H, Siesling S, Comber H, Katalinic A, Rosso S; Eurocourse WP3 Working Group.

J Registry Manag. 2014 Spring;41(1):31-7.

PMID:
24893186
18.

Bisphosphonates and their Role in Therapy for Breast Cancer - Results from the PATH Biobank.

Fick EM, Anzeneder T, Katalinic A, Waldmann A.

Geburtshilfe Frauenheilkd. 2013 May;73(5):412-421.

19.

Follow-up of probably benign lesions in non-screening breast diagnostics.

Kapsimalakou S, Waldmann A, Katalinic A, Grande-Nagel I, Fischer D, Barkhausen J, Vogt FM.

Arch Gynecol Obstet. 2014 Sep;290(3):543-51. doi: 10.1007/s00404-014-3233-5. Epub 2014 Apr 11.

PMID:
24722993
20.

Survival of adults with acute lymphoblastic leukemia in Germany and the United States.

Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H; GEKID Cancer Survival Working Group.

PLoS One. 2014 Jan 27;9(1):e85554. doi: 10.1371/journal.pone.0085554. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk